Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea after eating is one of the more common side effects reported by people taking Wegovy (semaglutide). It happens because semaglutide slows the speed at which food moves through the gut, and that change in motility can, paradoxically, trigger loose stools in some people — particularly in the first weeks of treatment or after a dose increase. The NHS patient information for semaglutide lists diarrhoea as a known common side effect. It is not a sign that the medicine is failing, and for most people it eases as the body adjusts — but there are situations where it warrants medical attention, and a prescriber should always know what you are experiencing.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The scenario is familiar to many Wegovy users: a meal that would normally cause no trouble sends you straight to the bathroom within half an hour. It feels alarming at first, and a common assumption is that something has gone wrong with the medicine or that the body is rejecting it. That is rarely the case.
Semaglutide works partly by slowing gastric emptying, the rate at which food leaves the stomach and enters the small intestine. This is one of the mechanisms behind reduced appetite. In some people, however, that altered motility does not simply slow things down uniformly; it can shift the balance in the lower gut and produce loose or urgent stools, particularly after a larger meal or one that is high in fat. The gut has GLP-1 receptors throughout its length, so semaglutide's effects are not confined to the stomach. If you want a closer look at why diarrhea after Wegovy tends to strike in the hours following a meal and what the pattern typically looks like, our dedicated page walks through it in detail. Most people find it peaks in the first four to eight weeks and gradually settles, or becomes manageable with small adjustments to how they eat. For practical detail on the broader picture of diarrhoea and Wegovy, our dedicated page covers frequency, duration and the wider pattern across treatment.
One thing worth noting: the timing (diarrhoea specifically after eating, rather than at random) is very typical of GI motility changes. If it is happening at other times, or without any food trigger, mention it to your prescriber, as the pattern matters clinically.
Not every meal carries the same risk. High-fat foods are the most consistently reported trigger: fatty cuts of meat, fried food, creamy sauces and rich pastries all slow gastric emptying further and can overwhelm the gut's adjusted rhythm. Very large portions have a similar effect. Eating quickly, barely chewing, and then lying down soon after are habits that the gut tolerates less well on semaglutide than it might have before.
Practical adjustments that many people on Wegovy find useful include eating smaller portions more slowly, choosing lower-fat protein sources, keeping fibre intake steady rather than dramatically increasing it, and staying well hydrated between meals rather than drinking a lot during them. Alcohol can also irritate the gut lining and worsen loose stools, particularly in the early weeks.
Our page on managing Wegovy side effects covers the full range of adjustments in more detail. If nausea is sitting alongside the diarrhoea, which is common, our page on feeling wegovy sick after eating may also be useful, as the dietary strategies overlap considerably with those for managing loose stools.
None of these changes replace advice from your prescriber or a registered dietitian, particularly if you are finding it difficult to eat enough protein or keep weight stable. Tell the team at your next check-in.
Most post-meal diarrhoea on Wegovy is uncomfortable rather than dangerous. There are situations, though, where you should not wait for your next scheduled review.
Get medical help the same day if you have diarrhoea that is severe, frequent and shows no sign of easing after 24 to 48 hours. Prolonged diarrhoea leads to dehydration, and dehydration on a GLP-1 medicine can put pressure on the kidneys. Signs that dehydration is taking hold include feeling very thirsty, producing much less urine than usual, dizziness when standing, and a dry mouth. If you cannot keep fluids down at all, contact your GP or call 111.
Diarrhoea accompanied by severe abdominal pain (especially pain that is persistent and radiates toward the back) should be assessed urgently. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, if infrequent, serious risk with GLP-1 medicines; severe stomach pain with or without vomiting is the key symptom to watch for. An allergic reaction (rash, swelling, difficulty breathing) is also a reason to seek immediate help.
Blood in your stool is not an expected side effect of Wegovy and should always be assessed promptly.
You can report any suspected side effect from a licensed medicine (including diarrhoea that seems severe or unusual) through the MHRA's Yellow Card scheme. This supports ongoing medicine safety monitoring and is open to patients as well as healthcare professionals.
If you are currently experiencing side effects and are unsure whether they are within the expected range, our support team is available seven days a week.
Persistent or severe post-meal diarrhoea is something a prescriber will want to address actively, not simply wait out. The options depend on what is driving it. Holding the current dose for an extra four weeks rather than escalating (the prescriber's call, based on your full picture) gives the gut more time to adjust before the next increase. In some cases, a lower dose is the right short-term move.
Your prescriber will also want to check that the diarrhoea is not masking something else: certain medications interact with semaglutide's effect on gut motility, and other GI conditions can be unmasked or worsened by GLP-1 treatment. This is one reason that clinical review before every dose change matters.
For those also experiencing fatigue alongside GI symptoms, the page on Wegovy and tiredness after eating is worth reading, the two often travel together, and some of the underlying reasons overlap. If an unsettled stomach after meals is part of your experience, our page on nausea after eating on Wegovy explains why this happens and how it tends to respond to the same kinds of dietary adjustments.
At nume, a GPhC-registered prescriber personally reviews your case before any repeat is approved, giving them the chance to adjust your plan if side effects are a problem. If you are considering starting treatment and want to discuss how side effects like diarrhoea after eating are managed from the outset, you can check your eligibility and our prescribers will talk through suitability with you as part of the consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.